跳至主要内容
临床试验/NCT01752439
NCT01752439Unknown不适用

Randomized Double-Blind Sham-Controlled Study of the Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache Patients

Dr Armando Perrotta, MD, PhD0 个研究点目标入组 30 人开始时间: 2013年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
主要终点
Change in headache days per months

研究概览

简要总结

The purpose of the study is to evaluate the efficacy of the transcranial direct current stimulation of the primary motor cortex (M1) in patients affected by refractory chronic migraine (coded as 1.5.1 in the international headache classification 2nd edition, 2004) and medication-overuse headache (coded as 8.1) with migraine as primary headache.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic MIgraine or Medication Overuse Headache according to the diagnostic criteria set out in the 2nd edition of the International Classification of Headache Disorders refractory to treatment according to the Refractory Headache Special Interest Section of the American Headache Society (Schulman et al., 2008)

排除标准

  • Other primary or secondary headaches.
  • Any serious systemic or neurological disease or psychiatric disorder.
  • Pregnancy or breastfeeding
  • Previous or current use of other or similar devices for pain control
  • Heart conduction and rhythm disorders
  • Cranial surgery
  • Other pain conditions, accordingly with current guidelines

结局指标

主要结局

Change in headache days per months

时间窗: at 30, 60 and 90 days after the treatment

Change in drugs intake per months

时间窗: at 30, 60 and 90 days after treatment

次要结局

  • Change in mean pain intensity score per months(at 30, 60 and 90 days after treatment)

研究者

发起方
Dr Armando Perrotta, MD, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr Armando Perrotta, MD, PhD

MD, PhD

Mediterranean Neurological Institute

相似试验